Synthetic lethal genetic screens in Ras mutant cancers.

Abstract excerpt

Mutations in the Ras family of small GTPases are among the most frequent oncogenic events in human cancer. Difficulties in targeting Ras itself and the limited efficacy in targeting its effector kinases have spurred the search for Ras synthetic lethal genes that could shed new light on the biology of Ras-driven cancer and lead to new therapeutic strategies. Advances in mammalian RNAi technology have enabled...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genes, Synthetic
• Share to Genetic Testing
• Share to Molecular Targeted Therapy